According to an official, the process of manufacturing drugs has been made easier. For this, the Ministry of Environment, Forest and Climate Change has amended the Environmental Impact Assessment (EIA) Notification 2006 following which all projects of drugs manufactured for the treatment of all diseases have been re-classified from the existing 'A' category to 'B2' category.
Projects falling in the 'B2' category have been exempted from the collection of baseline data, environmental impact assessment (EIA) studies and the need for public consultation.
This will now allow them to be evaluated at the state level which will accelerate the manufacturing as well as production of medicines.
The government has taken this step with the objective of increasing the availability of essential medicines in the country.
This amendment is applicable to all proposals received by September 30, 2020. The states have also been directed to increase such proposals at a fast pace.
Sources in the ministry said that within about two weeks, more than 100 proposals have been received within this category, which are to be decided by the authorities concerned.
(Navneet Mishra can be contacted at firstname.lastname@example.org)
Are you an Ayurveda doctor? Download our App from Google PlayStore now!
Download NirogStreet App for Ayurveda Doctors. Discuss cases with other doctors, share insights and experiences, read research papers and case studies. Get Free Consultation 9625991603 | 9625991607 | 8595299366
Secunderabad, Jan 19 (IANS) The South Central Railway (SCR) zone has jabbed the first shots of Coronavirus vaccine on its frontline staff at the central railway hospital in La...
Paris, Jan 19 (IANS) France on Monday reported 403 new Covid-19 deaths in the past 24 hours, the heaviest daily toll since November 24, raising the country's coronavirus-relat...
New York, Jan 19 (IANS) The total number of Covid-19 cases in the US topped 24 million on Monday, according to the Center for Systems Science and Engineering (CSSE) at Johns H...